Genomed Spólka Akcyjna reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was PLN 4.6 million compared to PLN 4.85 million a year ago. Net loss was PLN 0.559355 million compared to net income of PLN 0.379099 million a year ago.
For the six months, revenue was PLN 9.64 million compared to PLN 9.39 million a year ago. Net loss was PLN 0.390755 million compared to net income of PLN 0.061746 million a year ago.